CPT code 58580 represents transcervical radiofrequency ablation of uterine fibroids performed under ultrasound guidance. This minimally invasive gynecologic procedure offers an organ-preserving alternative to hysterectomy and uterine-sparing interventions, with implications for outpatient procedural care, device utilization, and reimbursement pathways nationwide. Key national payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise synthesis of what the code covers clinically, the typical sites of service, and the payer landscape. The publication outlines benchmark considerations for coverage and billing, highlights policy and coding updates relevant to adoption and reimbursement, and provides clinical context about indications and procedural settings. It also summarizes common modifiers and operational implications for facilities and clinicians. Data not available in the input is noted where applicable.